Sign In
Buy BDX
$145.61
+1.18 (+0.82%)
At Close: Jun 03, 2026
BD Announces Industry-First CE Marked Assay for HPV Screening from At-Home Self-Collected Vaginal Samples
06:00am, Thursday, 13'th May 2021
FRANKLIN LAKES, N.J., May 13, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the industry's first self-collection cla
Becton Dickinson To Spin Diabetes Care Unit In 2022
01:38pm, Tuesday, 11'th May 2021
, a leading global medical technology company, announced that its Board of Directors have unanimously authorized management to go ahead with a plan to spinoff the Diabetes Care business into an indepe
Becton, Dickinson & Co. Continues to Shine
12:11pm, Tuesday, 11'th May 2021
Becton, Dickinson & Co. ( BDX , Financial) delivered another strong top and bottom-line beat when it reported earnings results last week.
10 Of The Best Value Picks Among Dividend Aristocrats
07:45am, Saturday, 08'th May 2021
Dividend Aristocrats can be a great choice for investors looking for reliable income and stocks that can outperform during a recession. Not all Dividend Aristocrats are necessarily attractive at the s
Syringe maker Becton, Dickinson CEO on the Covid supply chain
03:32pm, Thursday, 06'th May 2021
CNBC's "Power Lunch" team discusses syringe supply and the Covid supply chain with Becton, Dickinson CEO Tom Polen.
Becton, Dickinson and Company (BDX) CEO Tom Polen on Q2 2021 Results - Earnings Call Transcript
02:28pm, Thursday, 06'th May 2021
Becton, Dickinson and Company (BDX) CEO Tom Polen on Q2 2021 Results - Earnings Call Transcript
Becton Dickinson (BDX) Earnings Surpass Estimates in Q2
01:31pm, Thursday, 06'th May 2021
Each of Becton Dickinson's (BDX) core units witnesses strong revenue growth in the fiscal second quarter.
Becton Dickinson To Spin-Off Diabetes Care Business: Highlights
12:53pm, Thursday, 06'th May 2021
While reporting financial results for the second fiscal quarter of the year, during which revenues grew more than 15% to $4.9 billion, Becton Dickinson and Co (NYSE: BDX) also laid out its plans
Becton Dickinson (BDX) Tops Q2 Earnings and Revenue Estimates
08:16am, Thursday, 06'th May 2021
Becton Dickinson (BDX) delivered earnings and revenue surprises of 4.93% and 1.47%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?
Becton Dickinson beats profit expectations, plans to spin off Diabetes Care business
06:15am, Thursday, 06'th May 2021
Becton Dickinson & Co. reported Thursday fiscal second-quarter profit and sales that rose above expectations, boosted by $480 million in COVID-19 testing sales, and announced plans to separate its Dia
BD Announces Intent to Spin Off Diabetes Care Business to Enhance Focus on Innovation and Priority Growth Markets
06:00am, Thursday, 06'th May 2021
FRANKLIN LAKES, N.J., May 6, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced its board of directors has unanimously a
BD (BDX) Gears Up for Q2 Earnings: What's in the Offing?
01:31pm, Monday, 03'rd May 2021
BD's (BDX) second-quarter fiscal 2021 results are likely to reflect strong year-over-year growth in revenues from assays in its Life Sciences segment.
BD to Present at Upcoming Investor Health Care Conferences in May
07:26pm, Thursday, 29'th Apr 2021
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced that it will present at the following
BD Announces Enrollment in Post-Market Studies of the WavelinQ™ Arteriovenous Endovascular Fistula
06:50am, Thursday, 29'th Apr 2021
FRANKLIN LAKES, N.J., April 29, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, announced today that enrollment has begun and the firs
Elizabeth McCombs Appointed Chief Technology Officer at BD
06:50am, Wednesday, 28'th Apr 2021
FRANKLIN LAKES, N.J., April 28, 2021 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the appointment of Elizabeth McCombs
